论文部分内容阅读
既往曾报道,静脉应用甲基泼尼松龙与安慰剂相比较可明显提高多发性硬化(MS)的缓解率。但迄今为止,有关口服糖皮质激素对MS疗效的安慰剂对照试验资料尚缺如。本文旨在评价口服大剂量甲基泼尼松龙对MS的疗效。
Previously reported that intravenous methylprednisolone compared with placebo can significantly improve the rate of multiple sclerosis (MS). However, to date, there is still a lack of data on placebo-controlled trials of the effect of oral glucocorticoids on MS. This article aims to evaluate the efficacy of oral high-dose methylprednisolone on MS.